Trenbolone hexahydrobenzylcarbonate Trade names Parabolan, Hexabolan Other names Trenbolone cyclohexylmethylcarbonate; Estra-4,9,11-trien-17β-ol-3-one 17β-cyclohexylmethylcarbonate Routes of administration Intramuscular injection Drug class Androgen; Anabolic steroid; Androgen ester; Progestogen
S,13 S,14 S,17 S)-13-methyl-3-oxo-2,6,7,8,14,15,16,17-octahydro-1 H-cyclopenta[ a]phenanthren-17-yl] carbonate CAS Number PubChem CID ChemSpider UNII CompTox Dashboard ( EPA) ECHA InfoCard 100.041.503 Formula C 26 H 34 O 4 Molar mass g·mol 410.554 −1 3D model ( JSmol)
Trenbolone hexahydrobenzylcarbonate, or trenbolone cyclohexylmethylcarbonate, sold under the brand names Parabolan and Hexabolan, is a synthetic, injected anabolic–androgenic steroid (AAS) of the nandrolone group and an androgen ester – specifically, the C17β hexahydrobenzylcarbonate (cyclohexylmethylcarbonate) ester of trenbolone – which was marketed in France for medical use in humans but has since been discontinued.
It was introduced in France in 1980 and was voluntarily discontinued by its manufacturer in 1997.
 The drug acts as a long-lasting  prodrug of trenbolone when administered via intramuscular injection. It was used clinically at a dosage of one  ampoule (76 mg, corresponding to 50 mg trenbolone base) every 10 days.
See also [ edit ]
References [ edit ]
Further reading [ edit ]
Yarrow JF, McCoy SC, Borst SE (2010). "Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity". Steroids. 75 (6): 377–89. doi: 10.1016/j.steroids.2010.01.019. PMID 20138077. S2CID 205253265.
External links [ edit ]